Beta-3 Enhanced Autonomic Therapy for POTS

NCT07585513 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Postural Orthostatic Tachycardia Syndrome (POTS)

Interventions

DRUG: Mirabegron
DRUG: Placebo

Sponsor

Cedars-Sinai Medical Center